Quarterly report pursuant to Section 13 or 15(d)

Loss Per Share (Tables)

v3.24.0.1
Loss Per Share (Tables)
6 Months Ended
Dec. 31, 2023
Loss Per Share [Abstract]  
Schedule of Common Stock Equivalents The Company had the following common stock equivalents at December 31, 2023 and 2022:
    December 31,
2023
    December 31,
2022
 
Convertible Notes     9,341,825       9,341,825  
Options     3,214,687       3,217,400  
Warrants    
      41,103  
Total     12,556,512       12,600,328